ARCHIVES

Consolidation Unlikely to Save Money

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997